Literature DB >> 16020942

Dimensions of executive function in Parkinson's disease.

Daniel Weintraub1, Paul J Moberg, William C Culbertson, John E Duda, Ira R Katz, Matthew B Stern.   

Abstract

BACKGROUND: Executive impairment is common in Parkinson's disease (PD). However, it is unknown which dimensions of executive function are assessed by commonly used neuropsychological instruments and if clinical correlates of specific dimensions exist.
METHOD: A convenience sample of 46 PD patients was evaluated with three executive function tests: the Tower of London-Drexel, the Trail-Making Test and the Stroop Color-Word Test. Factor analysis was used to probe for dimensions of executive control, and linear regression models were used to explore the association between the generated factors and other clinical features.
RESULTS: Factor analysis revealed two executive factors, one related to planning (eigenvalue=4.2) and the other to inhibitory control (eigenvalue=1.8), together accounting for 75% of the variance in scores. In linear regression models, poorer planning was associated with increasing severity of apathy (t=2.11, p=0.041), and diminished inhibitory control was associated with increasing severity of parkinsonism (t=2.78, p=0.008) and lower educational level (t=-2.23, p=0.032).
CONCLUSIONS: Planning deficits and diminished inhibitory control are two dimensions of executive impairment in PD, the former associated with decreased motivation and the latter with increased motor slowing. Similar performance on both executive and non-executive components of these instruments suggests that results of executive testing in PD may be confounded by non-executive deficits. Copyright (c) 2005 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2005        PMID: 16020942     DOI: 10.1159/000087043

Source DB:  PubMed          Journal:  Dement Geriatr Cogn Disord        ISSN: 1420-8008            Impact factor:   2.959


  15 in total

1.  Sentence processing in Lewy body spectrum disorder: the role of working memory.

Authors:  Rachel G Gross; Corey T McMillan; Keerthi Chandrasekaran; Michael Dreyfuss; Sharon Ash; Brian Avants; Philip Cook; Peachie Moore; David J Libon; Andrew Siderowf; Murray Grossman
Journal:  Brain Cogn       Date:  2012-01-02       Impact factor: 2.310

2.  Impairment of script comprehension in Lewy body spectrum disorders.

Authors:  Rachel G Gross; Emily Camp; Corey T McMillan; Michael Dreyfuss; Delani Gunawardena; Philip A Cook; Brianna Morgan; Andrew Siderowf; Howard I Hurtig; Matthew B Stern; Murray Grossman
Journal:  Brain Lang       Date:  2013-04-06       Impact factor: 2.381

3.  Computerized assessment of goal-directed behavior in Parkinson's disease.

Authors:  Whitney Fitts; Lauren Massimo; Nicholas Lim; Murray Grossman; Nabila Dahodwala
Journal:  J Clin Exp Neuropsychol       Date:  2016-06-07       Impact factor: 2.475

4.  The impact of antidepressant treatment on cognitive functioning in depressed patients with Parkinson's disease.

Authors:  Roseanne DeFronzo Dobkin; Matthew Menza; Karina L Bienfait; Michael Gara; Humberto Marin; Margery H Mark; Allison Dicke; Alexander Tröster
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2010       Impact factor: 2.198

5.  Mild cognitive impairment in Parkinson disease: a multicenter pooled analysis.

Authors:  D Aarsland; K Bronnick; C Williams-Gray; D Weintraub; K Marder; J Kulisevsky; D Burn; P Barone; J Pagonabarraga; L Allcock; G Santangelo; T Foltynie; C Janvin; J P Larsen; R A Barker; M Emre
Journal:  Neurology       Date:  2010-09-21       Impact factor: 9.910

6.  Impaired learning and memory in Pitx3 deficient aphakia mice: a genetic model for striatum-dependent cognitive symptoms in Parkinson's disease.

Authors:  Paul Ardayfio; Jisook Moon; Ka Ka Amanda Leung; Dong Youn-Hwang; Kwang-Soo Kim
Journal:  Neurobiol Dis       Date:  2008-06-04       Impact factor: 5.996

7.  Meta-analysis of neuropsychological symptoms of adolescents and adults with PKU.

Authors:  J J Moyle; A M Fox; M Arthur; M Bynevelt; J R Burnett
Journal:  Neuropsychol Rev       Date:  2007-04-05       Impact factor: 7.444

8.  The epidemiology and clinical manifestations of dysexecutive syndrome in Parkinson's disease.

Authors:  Roberto Ceravolo; Cristina Pagni; Gloria Tognoni; Ubaldo Bonuccelli
Journal:  Front Neurol       Date:  2012-11-08       Impact factor: 4.003

9.  Executive functioning in daily life in Parkinson's disease: initiative, planning and multi-task performance.

Authors:  Janneke Koerts; Marije Van Beilen; Oliver Tucha; Klaus L Leenders; Wiebo H Brouwer
Journal:  PLoS One       Date:  2011-12-20       Impact factor: 3.240

10.  Subthalamic nucleus deep brain stimulation does not improve visuo-motor impairment in Parkinson's disease.

Authors:  Simon D Israeli-Korn; Shraga Hocherman; Sharon Hassin-Baer; Oren S Cohen; Rivka Inzelberg
Journal:  PLoS One       Date:  2013-06-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.